Drug recall · August 23, 2017
Entecavir Tablets 0.5 mg recall
Why: Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Entecavir Tablets 0.5 mg, 30 tablets per container, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854. By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India. NDC 31722-833-30
- Lots / codes
Lot # ENT17008, Exp 01/2019
- Quantity
- 5664 bottles
- Company
- Hetero USA Inc, Piscataway, NJ
- Distribution
- NJ
- Initiated
- July 20, 2017 · Voluntary: Firm initiated
- Classified
- August 16, 2017
- Reported
- August 23, 2017
- Ended
- February 27, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Entecavir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.